文献速递胸部技术与安全CT

用于指导精准癌症治疗的肿瘤体积增长率自动图像分析工具:以EGFR突变非小细胞肺癌为范例

Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm.
PubMed 文献 · Eur J Radiol · 2018-10-23

本研究开发了一个自动分析模块,可从系列CT扫描计算肿瘤体积增长率,并在24例接受EGFR酪氨酸激酶抑制剂治疗的EGFR突变晚期非小细胞肺癌患者中评估其可重复性。模块分析共227次扫描,肿瘤增长率的观察者间和观察者内一致性相关系数分别为0.9323和0.9668,使用≤0.15/月阈值区分慢速与快速生长的观察者间κ=1.00、观察者内κ=0.895。

要点

  • 自动模块可在每例患者体积最低点后即时计算肿瘤体积增长率并以图形显示。
  • 肿瘤增长率观察者间一致性相关系数0.9323,观察者内0.9668。
  • 以≤0.15/月阈值区分慢速与快速生长,观察者间κ=1.00,观察者内κ=0.895。

核心结论

  • 本研究描述了用于评估肿瘤增长率的图像分析模块的开发,数据表明该模块在EGFR突变非小细胞肺癌接受EGFR-TKI治疗的试验队列中具有功能性和可重复性;该模块是将肿瘤增长率方法临床转化以指导精准肿瘤治疗的第一步。

研究设计与样本

  • 开发自动分析模块并应用于试验队列;模块基于配备经验证肿瘤体积测量工具的商业图像处理工作站;队列为24例接受EGFR抑制剂治疗的EGFR突变患者(5例男性、19例女性;中位年龄61岁),由两名独立胸部放射科医生测试可重复性。

诊断标准与关键数值

  • 肿瘤增长率由模块自动计算;采用既往确定的阈值≤0.15/月区分慢速与快速肿瘤生长,观察者间一致性κ=1.00,观察者内一致性κ=0.895;肿瘤增长率观察者间一致性相关系数0.9323,观察者内0.9668。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To develop an automated analytic module for calculation of tumor growth rate from serial CT scans and to apply the module and evaluate reproducibility in a pilot cohort of advanced NSCLC patients with EGFR mutations treated with EGFR tyrosine kinase inhibitors.

MATERIALS AND METHODS: The module utilized a commercially available image-processing workstation equipped with a validated tumor volume measurement tool. An automated analytic software module was programmed with the capability to record and display serial tumor volume changes and to calculate tumor volume growth rate over time and added to the workstation. The module was applied to evaluate the tumor growth rate in a pilot cohort of 24 EGFR-mutant patients treated with EGFR inhibitors, and reproducibility references as tested by two independent thoracic radiologists.

RESULTS: The module analyzed chest CT scans from 24 patients (5 males, 19 females; median age: 61) with a median of 8 scans per patient, totaling 227 scans and provided a graphical display with an automated and instant calculation of tumor growth rate after the nadir volume for each patient. High inter and intraobserver agreements were noted for tumor growth rates, with concordance correlation coefficients of 0.9323 and 0.9668, respectively. Interpretation of slow versus fast tumor growth using previously identified threshold of ≤0.15/month had a perfect interobserver agreement (κ = 1.00), and an excellent intraobserver agreement (κ = 0.895).

CONCLUSIONS: The present study describes the development of an image analytic module for assessing tumor growth rate and the data demonstrates the functionality and reproducibility of the module in a pilot cohort of EGFR-mutant NSCLC patients treated with EGFR-TKI. The image analytic module is an initial step for clinical translation of the tumor growth rate approach to guide cancer treatment in precision oncology.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Nishino M, Wakai S, Hida T, et al. Automated image analysis tool for tumor volume growth rate to guide precision cancer therapy: EGFR-mutant non-small-cell lung cancer as a paradigm. Eur J Radiol. 2018. PMID: 30527314. doi:10.1016/j.ejrad.2018.10.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。